In the pathophysiology of IPF, secretion of TGFβ1 has been identified as a significant driving factor in the progression of the fibrotic process by promoting differentiation of fibroblast into myofibroblast, resulting in abnormal ECM deposition [69,70,71]. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.